Accelerated API manufacturing by combining early-stage and late-stage process development

Traditionally, early-stage and late-stage process development have been done separately, with early-stage mostly focused on material production and late-stage on process intensification. As more molecules in development fall under an orphan or fast-track indication, the traditional approach of linear development stages can be counterproductive—not to mention expensive—due to investing resources in perfecting a process prior to early clinical phase success. Addressing some of the aspects of late-stage process development during the initial process development can help save valuable time following phase 1 clinical studies

Download our white paper for insights on:

• Seven considerations when combining early- and late-stage process development for fast-track drugs
• Late-stage development to commercialization
• When it comes to speed, Integrated process development counts

Download the White Paper